Takami Tomiyama

4.8k total citations
83 papers, 3.9k citations indexed

About

Takami Tomiyama is a scholar working on Physiology, Molecular Biology and Cellular and Molecular Neuroscience. According to data from OpenAlex, Takami Tomiyama has authored 83 papers receiving a total of 3.9k indexed citations (citations by other indexed papers that have themselves been cited), including 71 papers in Physiology, 34 papers in Molecular Biology and 16 papers in Cellular and Molecular Neuroscience. Recurrent topics in Takami Tomiyama's work include Alzheimer's disease research and treatments (70 papers), Cholinesterase and Neurodegenerative Diseases (13 papers) and Neuroscience and Neuropharmacology Research (12 papers). Takami Tomiyama is often cited by papers focused on Alzheimer's disease research and treatments (70 papers), Cholinesterase and Neurodegenerative Diseases (13 papers) and Neuroscience and Neuropharmacology Research (12 papers). Takami Tomiyama collaborates with scholars based in Japan, United States and Netherlands. Takami Tomiyama's co-authors include Hiroshi Mori, Tomohiro Umeda, Satoshi Asano, Noriaki Endo, William L. Klein, Mary P. Lambert, Hiroyuki Shimada, Hiroshi Takuma, Rie Teraoka and Ken-ichiro Kataoka and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Journal of Neuroscience.

In The Last Decade

Takami Tomiyama

82 papers receiving 3.8k citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Takami Tomiyama 2.9k 1.5k 787 712 610 83 3.9k
Elizabeth A. Eckman 2.6k 0.9× 1.6k 1.1× 577 0.7× 644 0.9× 611 1.0× 40 3.9k
Thierry Bussière 3.0k 1.1× 1.6k 1.0× 922 1.2× 720 1.0× 813 1.3× 29 4.1k
Steffen Roßner 2.6k 0.9× 2.0k 1.3× 1.4k 1.7× 840 1.2× 814 1.3× 114 4.9k
Suzanne Y. Guénette 3.6k 1.2× 2.2k 1.5× 908 1.2× 830 1.2× 527 0.9× 30 4.7k
Reisuke H. Takahashi 2.5k 0.9× 1.4k 0.9× 1.1k 1.4× 674 0.9× 533 0.9× 33 3.6k
Dieder Moechars 2.7k 0.9× 1.8k 1.2× 1.3k 1.7× 800 1.1× 395 0.6× 67 4.5k
Alfredo Lorenzo 3.1k 1.1× 2.1k 1.4× 874 1.1× 776 1.1× 582 1.0× 35 4.6k
Paul E. Fraser 2.8k 1.0× 1.7k 1.1× 799 1.0× 707 1.0× 728 1.2× 34 4.0k
Amaya García-Muñoz 2.5k 0.9× 1.6k 1.1× 933 1.2× 637 0.9× 573 0.9× 15 3.8k
Eduardo M. Castaño 3.8k 1.3× 2.5k 1.7× 585 0.7× 684 1.0× 672 1.1× 73 4.9k

Countries citing papers authored by Takami Tomiyama

Since Specialization
Citations

This map shows the geographic impact of Takami Tomiyama's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Takami Tomiyama with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Takami Tomiyama more than expected).

Fields of papers citing papers by Takami Tomiyama

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Takami Tomiyama. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Takami Tomiyama. The network helps show where Takami Tomiyama may publish in the future.

Co-authorship network of co-authors of Takami Tomiyama

This figure shows the co-authorship network connecting the top 25 collaborators of Takami Tomiyama. A scholar is included among the top collaborators of Takami Tomiyama based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Takami Tomiyama. Takami Tomiyama is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Umeda, Tomohiro, et al.. (2024). New Value of Acorus tatarinowii/gramineus Leaves as a Dietary Source for Dementia Prevention. Nutrients. 16(11). 1589–1589. 3 indexed citations
2.
Chang, Chia-Jung, Zacharie Taoufiq, Hiroshi Yamada, et al.. (2024). The microtubule-dynamin binding inhibitor peptide PHDP5 rescues spatial learning and memory deficits in Alzheimer’s disease model mice. Brain Research. 1838. 148987–148987. 2 indexed citations
3.
4.
Nomura, Sachiko, et al.. (2022). Peripheral Aβ acts as a negative modulator of insulin secretion. Proceedings of the National Academy of Sciences. 119(12). e2117723119–e2117723119. 9 indexed citations
5.
Umeda, Tomohiro, et al.. (2022). C9orf72 Hexanucleotide Repeat Expansion-Related Neuropathology Is Attenuated by Nasal Rifampicin in Mice. Biomedicines. 10(5). 1080–1080. 3 indexed citations
6.
Umeda, Tomohiro, et al.. (2021). Oligomer-Targeting Prevention of Neurodegenerative Dementia by Intranasal Rifampicin and Resveratrol Combination – A Preclinical Study in Model Mice. Frontiers in Neuroscience. 15. 763476–763476. 21 indexed citations
7.
Shimada, Hiroyuki, Jun Takeuchi, Akitoshi Takeda, et al.. (2020). Heavy Tau Burden with Subtle Amyloid β Accumulation in the Cerebral Cortex and Cerebellum in a Case of Familial Alzheimer’s Disease with APP Osaka Mutation. International Journal of Molecular Sciences. 21(12). 4443–4443. 9 indexed citations
8.
Wada‐Kakuda, Satoko, Makoto Matsuyama, Akihiko Takashima, et al.. (2019). Ectopic Expression Induces Abnormal Somatodendritic Distribution of Tau in the Mouse Brain. Journal of Neuroscience. 39(34). 6781–6797. 12 indexed citations
9.
Furiya, Yoshiko, et al.. (2018). Rivastigmine Improves Appetite by Increasing the Plasma Acyl/Des-Acyl Ghrelin Ratio and Cortisol in Alzheimer Disease. Dementia and Geriatric Cognitive Disorders Extra. 8(1). 77–84. 14 indexed citations
10.
Umeda, Tomohiro, Tetsuya Kimura, Kayo Yoshida, et al.. (2017). Mutation-induced loss of APP function causes GABAergic depletion in recessive familial Alzheimer’s disease: analysis of Osaka mutation-knockin mice. Acta Neuropathologica Communications. 5(1). 59–59. 21 indexed citations
11.
Umeda, Tomohiro, Kenjiro Ono, M. Yamashita, et al.. (2016). Rifampicin is a candidate preventive medicine against amyloid-β and tau oligomers. Brain. 139(5). 1568–1586. 100 indexed citations
12.
Umeda, Tomohiro, Takenari Yamashita, Tetsuya Kimura, et al.. (2013). Neurodegenerative Disorder FTDP-17–Related Tau Intron 10 +16C→T Mutation Increases Tau Exon 10 Splicing and Causes Tauopathy in Transgenic Mice. American Journal Of Pathology. 183(1). 211–225. 35 indexed citations
13.
Umeda, Tomohiro, Takami Tomiyama, Sachiko Nomura, et al.. (2012). Hypercholesterolemia accelerates intraneuronal accumulation of Aβ oligomers resulting in memory impairment in Alzheimer's disease model mice. Life Sciences. 91(23-24). 1169–1176. 63 indexed citations
14.
Suzuki, Takayuki, Kazuma Murakami, Naotaka Izuo, et al.. (2010). E22Δ Mutation in Amyloid β‐Protein Promotes β‐Sheet Transformation, Radical Production, and Synaptotoxicity, But Not Neurotoxicity. International Journal of Alzheimer s Disease. 2011(1). 431320–431320. 16 indexed citations
15.
Ito, Kazuhiro, Kenichi Ishibashi, Takami Tomiyama, et al.. (2009). Oligomeric Amyloid β -Protein as a Therapeutic Target in Alzheimers Disease: Its Significance Based on its Distinct Localization and the Occurrence of a Familial Variant Form. Current Alzheimer Research. 6(2). 132–136. 3 indexed citations
16.
Tomiyama, Takami, Tetsu Nagata, Hiroyuki Shimada, et al.. (2008). A new amyloid β variant favoring oligomerization in Alzheimer's‐type dementia. Annals of Neurology. 63(3). 377–387. 335 indexed citations
17.
Ono, Masahiro, et al.. (2007). Structure–activity relationship of chalcones and related derivatives as ligands for detecting of β-amyloid plaques in the brain. Bioorganic & Medicinal Chemistry. 15(19). 6388–6396. 44 indexed citations
18.
Boekhoorn, Karin, Dick Terwel, Peter Borghgraef, et al.. (2006). Improved Long-Term Potentiation and Memory in Young Tau-P301L Transgenic Mice before Onset of Hyperphosphorylation and Tauopathy. Journal of Neuroscience. 26(13). 3514–3523. 137 indexed citations
19.
Ishibashi, Kenichi, Takami Tomiyama, Kazuchika Nishitsuji, Mitsuhiro Hara, & Hiroshi Mori. (2006). Absence of synaptophysin near cortical neurons containing oligomer Aβ in Alzheimer's disease brain. Journal of Neuroscience Research. 84(3). 632–636. 33 indexed citations
20.
Tomiyama, Takami, et al.. (2005). Syntaxin 5 interacts specifically with presenilin holoproteins and affects processing of βAPP in neuronal cells. Journal of Neurochemistry. 94(2). 425–439. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Elizabeth A. Eckman Breakdown of academic impact, for papers by Thierry Bussière Breakdown of academic impact, for papers by Steffen Roßner Breakdown of academic impact, for papers by Suzanne Y. Guénette Breakdown of academic impact, for papers by Reisuke H. Takahashi Breakdown of academic impact, for papers by Dieder Moechars Breakdown of academic impact, for papers by Alfredo Lorenzo Breakdown of academic impact, for papers by Paul E. Fraser Breakdown of academic impact, for papers by Amaya García-Muñoz Breakdown of academic impact, for papers by Eduardo M. Castaño
Rankless by CCL
2026